The announcement of a class action lawsuit against Applied Therapeutics, Inc. is likely to negatively impact its stock price in the short term as investors may react to the potential legal and financial consequences. The lawsuit suggests possible issues with the company's disclosures or operations, which could lead to uncertainty and a lack of confidence among investors.